nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCB1—peripheral nervous system neoplasm	0.261	1	CbGaD
Venlafaxine—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0669	0.142	CbGbCtD
Venlafaxine—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0464	0.0985	CbGbCtD
Venlafaxine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0437	0.0929	CbGbCtD
Venlafaxine—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0286	0.0606	CbGbCtD
Venlafaxine—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0266	0.0566	CbGbCtD
Venlafaxine—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0262	0.0556	CbGbCtD
Venlafaxine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0241	0.0512	CbGbCtD
Venlafaxine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0241	0.0512	CbGbCtD
Venlafaxine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0231	0.0491	CbGbCtD
Venlafaxine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0187	0.0398	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0178	0.0379	CbGbCtD
Venlafaxine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0167	0.0355	CbGbCtD
Venlafaxine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0145	0.0307	CbGbCtD
Venlafaxine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0134	0.0285	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0126	0.0267	CbGbCtD
Venlafaxine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0103	0.0219	CbGbCtD
Venlafaxine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00989	0.021	CbGbCtD
Venlafaxine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0096	0.0204	CbGbCtD
Venlafaxine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00943	0.02	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00643	0.0137	CbGbCtD
Venlafaxine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00617	0.0131	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00606	0.0129	CbGbCtD
Venlafaxine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00565	0.012	CbGbCtD
Venlafaxine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00386	0.00819	CbGbCtD
Venlafaxine—NPY1R—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.00194	0.0935	CbGpPWpGaD
Venlafaxine—Cyclopentolate—BCHE—peripheral nervous system neoplasm	0.00193	1	CrCbGaD
Venlafaxine—SLC6A3—Parkinsons Disease Pathway—PINK1—peripheral nervous system neoplasm	0.00135	0.0651	CbGpPWpGaD
Venlafaxine—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.001	0.0485	CbGpPWpGaD
Venlafaxine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.000996	0.0481	CbGpPWpGaD
Venlafaxine—SLC6A4—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.000901	0.0435	CbGpPWpGaD
Venlafaxine—NPY1R—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	0.000824	0.0398	CbGpPWpGaD
Venlafaxine—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000585	0.0283	CbGpPWpGaD
Venlafaxine—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000577	0.0279	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.000517	0.025	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000433	0.0209	CbGpPWpGaD
Venlafaxine—SLC6A4—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000406	0.0196	CbGpPWpGaD
Venlafaxine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000351	0.017	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000349	0.0168	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000347	0.0168	CbGpPWpGaD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—TH—peripheral nervous system neoplasm	0.000325	0.0157	CbGpPWpGaD
Venlafaxine—SLC6A3—Alpha-synuclein signaling—TH—peripheral nervous system neoplasm	0.000317	0.0153	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000309	0.0149	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000275	0.0133	CbGpPWpGaD
Venlafaxine—SLC6A3—Parkinsons Disease Pathway—TH—peripheral nervous system neoplasm	0.000269	0.013	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000264	0.0128	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000253	0.0122	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.000232	0.0112	CbGpPWpGaD
Venlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00023	0.0111	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000196	0.00947	CbGpPWpGaD
Venlafaxine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000195	0.00942	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000171	0.00828	CbGpPWpGaD
Venlafaxine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000167	0.00806	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000162	0.00782	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000162	0.0078	CbGpPWpGaD
Venlafaxine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000159	0.00768	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000156	0.00753	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000149	0.00721	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000136	0.00655	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00013	0.00628	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000128	0.00616	CbGpPWpGaD
Venlafaxine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000126	0.00609	CbGpPWpGaD
Venlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000126	0.00607	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000125	0.00602	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000122	0.0059	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000119	0.00573	CbGpPWpGaD
Venlafaxine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000115	0.00555	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000114	0.00552	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000113	0.00546	CbGpPWpGaD
Venlafaxine—SLC6A3—Parkinsons Disease Pathway—CASP3—peripheral nervous system neoplasm	0.00011	0.00529	CbGpPWpGaD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000109	0.00529	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000105	0.00508	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000104	0.00501	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000103	0.00496	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.48e-05	0.00458	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—HGF—peripheral nervous system neoplasm	9.37e-05	0.00452	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TH—peripheral nervous system neoplasm	9.33e-05	0.0045	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	9.31e-05	0.0045	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	9.3e-05	0.00449	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	8.73e-05	0.00422	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	8.3e-05	0.00401	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—HGF—peripheral nervous system neoplasm	8.05e-05	0.00389	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.01e-05	0.00387	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.68e-05	0.00371	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	7.59e-05	0.00366	CbGpPWpGaD
Venlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	7.58e-05	0.00366	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	7.33e-05	0.00354	CbGpPWpGaD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	7.23e-05	0.00349	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.22e-05	0.00349	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	7.13e-05	0.00345	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.71e-05	0.00324	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.62e-05	0.0032	CbGpPWpGaD
Venlafaxine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	6.42e-05	0.0031	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.36e-05	0.00307	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.09e-05	0.00294	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.07e-05	0.00293	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	5.87e-05	0.00283	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.87e-05	0.00283	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—BCHE—peripheral nervous system neoplasm	5.81e-05	0.00281	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.63e-05	0.00272	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.6e-05	0.00271	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.38e-05	0.0026	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.33e-05	0.00257	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.18e-05	0.0025	CbGpPWpGaD
Venlafaxine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000197	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000197	CcSEcCtD
Venlafaxine—Asthma—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000196	CcSEcCtD
Venlafaxine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000196	CcSEcCtD
Venlafaxine—Influenza—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000196	CcSEcCtD
Venlafaxine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000196	CcSEcCtD
Venlafaxine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	4.81e-05	0.000196	CcSEcCtD
Venlafaxine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	4.79e-05	0.000195	CcSEcCtD
Venlafaxine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000194	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000194	CcSEcCtD
Venlafaxine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	4.76e-05	0.000193	CcSEcCtD
Venlafaxine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	4.75e-05	0.000193	CcSEcCtD
Venlafaxine—Weight increased—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000193	CcSEcCtD
Venlafaxine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000192	CcSEcCtD
Venlafaxine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000192	CcSEcCtD
Venlafaxine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	4.71e-05	0.000192	CcSEcCtD
Venlafaxine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000191	CcSEcCtD
Venlafaxine—Somnolence—Etoposide—peripheral nervous system neoplasm	4.7e-05	0.000191	CcSEcCtD
Venlafaxine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000191	CcSEcCtD
Venlafaxine—Asthenia—Vincristine—peripheral nervous system neoplasm	4.68e-05	0.000191	CcSEcCtD
Venlafaxine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.00019	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	4.65e-05	0.00225	CbGpPWpGaD
Venlafaxine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.65e-05	0.000189	CcSEcCtD
Venlafaxine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000189	CcSEcCtD
Venlafaxine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.64e-05	0.000189	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000187	CcSEcCtD
Venlafaxine—Rash—Dactinomycin—peripheral nervous system neoplasm	4.61e-05	0.000187	CcSEcCtD
Venlafaxine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.6e-05	0.000187	CcSEcCtD
Venlafaxine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000186	CcSEcCtD
Venlafaxine—Renal failure—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.000186	CcSEcCtD
Venlafaxine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.56e-05	0.000186	CcSEcCtD
Venlafaxine—Fatigue—Etoposide—peripheral nervous system neoplasm	4.56e-05	0.000185	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000185	CcSEcCtD
Venlafaxine—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000184	CcSEcCtD
Venlafaxine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000184	CcSEcCtD
Venlafaxine—Pain—Etoposide—peripheral nervous system neoplasm	4.52e-05	0.000184	CcSEcCtD
Venlafaxine—Constipation—Etoposide—peripheral nervous system neoplasm	4.52e-05	0.000184	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.52e-05	0.00218	CbGpPWpGaD
Venlafaxine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000184	CcSEcCtD
Venlafaxine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000183	CcSEcCtD
Venlafaxine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000183	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000182	CcSEcCtD
Venlafaxine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.48e-05	0.000182	CcSEcCtD
Venlafaxine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.47e-05	0.000182	CcSEcCtD
Venlafaxine—Sweating—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000181	CcSEcCtD
Venlafaxine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000181	CcSEcCtD
Venlafaxine—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.00018	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.000179	CcSEcCtD
Venlafaxine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000179	CcSEcCtD
Venlafaxine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000178	CcSEcCtD
Venlafaxine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000177	CcSEcCtD
Venlafaxine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000177	CcSEcCtD
Venlafaxine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.36e-05	0.000177	CcSEcCtD
Venlafaxine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000177	CcSEcCtD
Venlafaxine—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.34e-05	0.000177	CcSEcCtD
Venlafaxine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000176	CcSEcCtD
Venlafaxine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000176	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.32e-05	0.000176	CcSEcCtD
Venlafaxine—Dizziness—Vincristine—peripheral nervous system neoplasm	4.32e-05	0.000176	CcSEcCtD
Venlafaxine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.31e-05	0.000175	CcSEcCtD
Venlafaxine—Rash—Alitretinoin—peripheral nervous system neoplasm	4.27e-05	0.000174	CcSEcCtD
Venlafaxine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.27e-05	0.000174	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000173	CcSEcCtD
Venlafaxine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.25e-05	0.000173	CcSEcCtD
Venlafaxine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.25e-05	0.000173	CcSEcCtD
Venlafaxine—Headache—Alitretinoin—peripheral nervous system neoplasm	4.24e-05	0.000173	CcSEcCtD
Venlafaxine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000172	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000171	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.21e-05	0.00203	CbGpPWpGaD
Venlafaxine—Urticaria—Etoposide—peripheral nervous system neoplasm	4.2e-05	0.000171	CcSEcCtD
Venlafaxine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000171	CcSEcCtD
Venlafaxine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.00017	CcSEcCtD
Venlafaxine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.00017	CcSEcCtD
Venlafaxine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.00017	CcSEcCtD
Venlafaxine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.18e-05	0.00017	CcSEcCtD
Venlafaxine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.18e-05	0.00017	CcSEcCtD
Venlafaxine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.00017	CcSEcCtD
Venlafaxine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.00017	CcSEcCtD
Venlafaxine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.00017	CcSEcCtD
Venlafaxine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000169	CcSEcCtD
Venlafaxine—Vomiting—Vincristine—peripheral nervous system neoplasm	4.15e-05	0.000169	CcSEcCtD
Venlafaxine—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.14e-05	0.000168	CcSEcCtD
Venlafaxine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000168	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.12e-05	0.00199	CbGpPWpGaD
Venlafaxine—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000168	CcSEcCtD
Venlafaxine—Rash—Vincristine—peripheral nervous system neoplasm	4.12e-05	0.000167	CcSEcCtD
Venlafaxine—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.11e-05	0.000167	CcSEcCtD
Venlafaxine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000167	CcSEcCtD
Venlafaxine—Headache—Vincristine—peripheral nervous system neoplasm	4.09e-05	0.000166	CcSEcCtD
Venlafaxine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000165	CcSEcCtD
Venlafaxine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000164	CcSEcCtD
Venlafaxine—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.02e-05	0.000164	CcSEcCtD
Venlafaxine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000164	CcSEcCtD
Venlafaxine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000163	CcSEcCtD
Venlafaxine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	3.95e-05	0.000161	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.95e-05	0.00191	CbGpPWpGaD
Venlafaxine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.00016	CcSEcCtD
Venlafaxine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.00016	CcSEcCtD
Venlafaxine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.9e-05	0.000158	CcSEcCtD
Venlafaxine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000158	CcSEcCtD
Venlafaxine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000158	CcSEcCtD
Venlafaxine—Nausea—Vincristine—peripheral nervous system neoplasm	3.88e-05	0.000158	CcSEcCtD
Venlafaxine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000158	CcSEcCtD
Venlafaxine—Flushing—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000158	CcSEcCtD
Venlafaxine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000157	CcSEcCtD
Venlafaxine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000157	CcSEcCtD
Venlafaxine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000157	CcSEcCtD
Venlafaxine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000156	CcSEcCtD
Venlafaxine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000156	CcSEcCtD
Venlafaxine—Asthenia—Etoposide—peripheral nervous system neoplasm	3.79e-05	0.000154	CcSEcCtD
Venlafaxine—Chills—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000152	CcSEcCtD
Venlafaxine—Pruritus—Etoposide—peripheral nervous system neoplasm	3.74e-05	0.000152	CcSEcCtD
Venlafaxine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000152	CcSEcCtD
Venlafaxine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000151	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.7e-05	0.00179	CbGpPWpGaD
Venlafaxine—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.00015	CcSEcCtD
Venlafaxine—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.67e-05	0.000149	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.000148	CcSEcCtD
Venlafaxine—Rash—Cisplatin—peripheral nervous system neoplasm	3.64e-05	0.000148	CcSEcCtD
Venlafaxine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.64e-05	0.000148	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.64e-05	0.00176	CbGpPWpGaD
Venlafaxine—Erythema—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000148	CcSEcCtD
Venlafaxine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.62e-05	0.000147	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000146	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.6e-05	0.00174	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.59e-05	0.00173	CbGpPWpGaD
Venlafaxine—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Venlafaxine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Venlafaxine—Tension—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000145	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000145	CcSEcCtD
Venlafaxine—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000143	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—peripheral nervous system neoplasm	3.51e-05	0.000143	CcSEcCtD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.51e-05	0.00169	CbGpPWpGaD
Venlafaxine—Dizziness—Etoposide—peripheral nervous system neoplasm	3.5e-05	0.000142	CcSEcCtD
Venlafaxine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000142	CcSEcCtD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.47e-05	0.00168	CbGpPWpGaD
Venlafaxine—Chills—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000141	CcSEcCtD
Venlafaxine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.00014	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.43e-05	0.00166	CbGpPWpGaD
Venlafaxine—Nausea—Cisplatin—peripheral nervous system neoplasm	3.43e-05	0.000139	CcSEcCtD
Venlafaxine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000139	CcSEcCtD
Venlafaxine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000139	CcSEcCtD
Venlafaxine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.37e-05	0.000137	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.37e-05	0.00163	CbGpPWpGaD
Venlafaxine—Vomiting—Etoposide—peripheral nervous system neoplasm	3.36e-05	0.000137	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000137	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000137	CcSEcCtD
Venlafaxine—Agitation—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000136	CcSEcCtD
Venlafaxine—Rash—Etoposide—peripheral nervous system neoplasm	3.33e-05	0.000136	CcSEcCtD
Venlafaxine—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.33e-05	0.000135	CcSEcCtD
Venlafaxine—Headache—Etoposide—peripheral nervous system neoplasm	3.31e-05	0.000135	CcSEcCtD
Venlafaxine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000135	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000134	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000134	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000133	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.27e-05	0.00158	CbGpPWpGaD
Venlafaxine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000133	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000133	CcSEcCtD
Venlafaxine—Syncope—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000132	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000132	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000132	CcSEcCtD
Venlafaxine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000131	CcSEcCtD
Venlafaxine—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000131	CcSEcCtD
Venlafaxine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.00013	CcSEcCtD
Venlafaxine—Cough—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000129	CcSEcCtD
Venlafaxine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000129	CcSEcCtD
Venlafaxine—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000128	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.15e-05	0.00152	CbGpPWpGaD
Venlafaxine—Nausea—Etoposide—peripheral nervous system neoplasm	3.14e-05	0.000128	CcSEcCtD
Venlafaxine—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000128	CcSEcCtD
Venlafaxine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.12e-05	0.000127	CcSEcCtD
Venlafaxine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000126	CcSEcCtD
Venlafaxine—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000126	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000126	CcSEcCtD
Venlafaxine—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000126	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000126	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000125	CcSEcCtD
Venlafaxine—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000124	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.03e-05	0.00147	CbGpPWpGaD
Venlafaxine—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000123	CcSEcCtD
Venlafaxine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000123	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000123	CcSEcCtD
Venlafaxine—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000123	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000122	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3e-05	0.00145	CbGpPWpGaD
Venlafaxine—Confusional state—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000122	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.98e-05	0.00144	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.98e-05	0.00144	CbGpPWpGaD
Venlafaxine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000121	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000121	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000121	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.00012	CcSEcCtD
Venlafaxine—Infection—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.00012	CcSEcCtD
Venlafaxine—Cough—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000119	CcSEcCtD
Venlafaxine—Shock—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000119	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000118	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.91e-05	0.00141	CbGpPWpGaD
Venlafaxine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000118	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000118	CcSEcCtD
Venlafaxine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000118	CcSEcCtD
Venlafaxine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000117	CcSEcCtD
Venlafaxine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000116	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000116	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000116	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000116	CcSEcCtD
Venlafaxine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000115	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.83e-05	0.000115	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.8e-05	0.00135	CbGpPWpGaD
Venlafaxine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.000114	CcSEcCtD
Venlafaxine—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000113	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000112	CcSEcCtD
Venlafaxine—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000112	CcSEcCtD
Venlafaxine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000112	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.74e-05	0.00132	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.74e-05	0.00132	CbGpPWpGaD
Venlafaxine—Infection—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000111	CcSEcCtD
Venlafaxine—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.72e-05	0.00131	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.71e-05	0.00131	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.7e-05	0.00011	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.00011	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.000109	CcSEcCtD
Venlafaxine—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000109	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000109	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.67e-05	0.00129	CbGpPWpGaD
Venlafaxine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000108	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.66e-05	0.00128	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000108	CcSEcCtD
Venlafaxine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000107	CcSEcCtD
Venlafaxine—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000107	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.63e-05	0.00127	CbGpPWpGaD
Venlafaxine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000106	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.61e-05	0.000106	CcSEcCtD
Venlafaxine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000105	CcSEcCtD
Venlafaxine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000104	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.56e-05	0.000104	CcSEcCtD
Venlafaxine—Constipation—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000103	CcSEcCtD
Venlafaxine—Pain—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000103	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.52e-05	0.00122	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000102	CcSEcCtD
Venlafaxine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000101	CcSEcCtD
Venlafaxine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.0001	CcSEcCtD
Venlafaxine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	9.95e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.44e-05	9.94e-05	CcSEcCtD
Venlafaxine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	9.92e-05	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.43e-05	0.00118	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.43e-05	0.00117	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.42e-05	9.86e-05	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	9.82e-05	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.4e-05	0.00116	CbGpPWpGaD
Venlafaxine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	9.7e-05	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	9.62e-05	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.36e-05	9.58e-05	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.35e-05	0.00114	CbGpPWpGaD
Venlafaxine—Pain—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	9.54e-05	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	9.54e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.34e-05	9.53e-05	CcSEcCtD
Venlafaxine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.34e-05	9.53e-05	CcSEcCtD
Venlafaxine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.26e-05	9.19e-05	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	9.12e-05	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.23e-05	0.00108	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.21e-05	0.00107	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.19e-05	0.00106	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.18e-05	8.88e-05	CcSEcCtD
Venlafaxine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	8.86e-05	CcSEcCtD
Venlafaxine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	8.82e-05	CcSEcCtD
Venlafaxine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	8.82e-05	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.16e-05	0.00105	CbGpPWpGaD
Venlafaxine—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.13e-05	8.65e-05	CcSEcCtD
Venlafaxine—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.1e-05	8.53e-05	CcSEcCtD
Venlafaxine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.03e-05	8.25e-05	CcSEcCtD
Venlafaxine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	8.22e-05	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.01e-05	0.000973	CbGpPWpGaD
Venlafaxine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.97e-05	8e-05	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.97e-05	0.00095	CbGpPWpGaD
Venlafaxine—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.96e-05	7.97e-05	CcSEcCtD
Venlafaxine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	7.89e-05	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.93e-05	0.000931	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.9e-05	0.000916	CbGpPWpGaD
Venlafaxine—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.88e-05	7.67e-05	CcSEcCtD
Venlafaxine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	7.63e-05	CcSEcCtD
Venlafaxine—Rash—Epirubicin—peripheral nervous system neoplasm	1.87e-05	7.6e-05	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.87e-05	7.6e-05	CcSEcCtD
Venlafaxine—Headache—Epirubicin—peripheral nervous system neoplasm	1.86e-05	7.55e-05	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.85e-05	0.000895	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.85e-05	0.000892	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.84e-05	0.000887	CbGpPWpGaD
Venlafaxine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.81e-05	7.38e-05	CcSEcCtD
Venlafaxine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.79e-05	0.000866	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.78e-05	0.00086	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.78e-05	0.000859	CbGpPWpGaD
Venlafaxine—Nausea—Epirubicin—peripheral nervous system neoplasm	1.76e-05	7.16e-05	CcSEcCtD
Venlafaxine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	7.09e-05	CcSEcCtD
Venlafaxine—Rash—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	7.03e-05	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.73e-05	0.000835	CbGpPWpGaD
Venlafaxine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	7.03e-05	CcSEcCtD
Venlafaxine—Headache—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	6.99e-05	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.67e-05	0.000808	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.65e-05	0.000797	CbGpPWpGaD
Venlafaxine—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.63e-05	6.63e-05	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.63e-05	0.000786	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.59e-05	0.000769	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.58e-05	0.000765	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.57e-05	0.000758	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.53e-05	0.000737	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.5e-05	0.000723	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.48e-05	0.000716	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.46e-05	0.000703	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.44e-05	0.000694	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.42e-05	0.000686	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.4e-05	0.000674	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	1.36e-05	0.000659	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.36e-05	0.000658	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.35e-05	0.00065	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.34e-05	0.000649	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.34e-05	0.000647	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.33e-05	0.000641	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.31e-05	0.000635	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.31e-05	0.000634	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.28e-05	0.00062	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.28e-05	0.00062	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.27e-05	0.000615	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.27e-05	0.000611	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.24e-05	0.000597	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.23e-05	0.000592	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.22e-05	0.000592	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.21e-05	0.000585	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.19e-05	0.000576	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.17e-05	0.000565	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.17e-05	0.000564	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000499	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.00049	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.01e-05	0.000486	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	9.86e-06	0.000476	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.62e-06	0.000465	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	9.6e-06	0.000464	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.41e-06	0.000455	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	9.27e-06	0.000448	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	8.82e-06	0.000426	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	8.76e-06	0.000423	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	8.61e-06	0.000416	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.49e-06	0.00041	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	8.39e-06	0.000405	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	8.11e-06	0.000392	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.11e-06	0.000392	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.08e-06	0.00039	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	8.04e-06	0.000389	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	7.57e-06	0.000366	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	7.45e-06	0.00036	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.43e-06	0.000359	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.28e-06	0.000351	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.11e-06	0.000343	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.01e-06	0.000339	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.94e-06	0.000335	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	6.86e-06	0.000331	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.84e-06	0.00033	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.8e-06	0.000328	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.54e-06	0.000316	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.48e-06	0.000313	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	6.45e-06	0.000311	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	6.39e-06	0.000309	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.72e-06	0.000276	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.61e-06	0.000271	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.58e-06	0.00027	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.31e-06	0.000256	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	5.26e-06	0.000254	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	5.22e-06	0.000252	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.16e-06	0.000249	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.12e-06	0.000247	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.48e-06	0.000217	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.28e-06	0.000207	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.21e-06	0.000204	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.44e-06	0.000166	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.38e-06	0.000163	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.79e-06	0.000135	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	2.04e-06	9.87e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.54e-06	7.46e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.51e-06	7.28e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.42e-06	6.86e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-06	6.8e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.29e-07	4.49e-05	CbGpPWpGaD
